Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review

March 2021 | 57 pages | ID: AA344728AD2EN
GlobalData

Abstracts

Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Acorda Therapeutics Inc (Acorda), is a biopharmaceutical company that discovers, develops, and markets therapies for treating patients with neurological disorders. Its portfolio encompasses marketed products for the treatment of multiple sclerosis (MS) and for the intermittent treatment of people with Parkinson’s taking levodopa or carbidopa who experience off episodes. It is also developing a pipeline of neurological therapies addressing a range of disorders, including MS and heart failure. The company sells its products through wholesale pharmaceutical distributors to retail pharmacies and specialty pharmacy providers. It has subsidiaries in the US and Europe. Acorda is headquartered in Ardsley, New York, the US.

Acorda Therapeutics Inc Key Recent Developments

Mar 04,2021: Acorda Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 19,2021: Acorda Therapeutics announces departure of Chief, Business Operations
Nov 03,2020: Acorda reports third quarter 2020 financial results
Aug 04,2020: Acorda reports second quarter 2020 financial results
Jul 14,2020: Acorda Therapeutics receives U.S. income tax refund

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Acorda Therapeutics Inc - Key Facts
Acorda Therapeutics Inc - Key Employees
Acorda Therapeutics Inc - Key Employee Biographies
Acorda Therapeutics Inc - Major Products and Services
Acorda Therapeutics Inc - History
Acorda Therapeutics Inc - Company Statement
Acorda Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Acorda Therapeutics Inc - Business Description
Product Category: Ampyra
Overview
Performance
Product Category: Inbrija
Overview
Performance
Product Category: Other
Performance
Product Category: Milestone Revenues
Performance
Product Category: Net Product Revenue
Performance
Product Category: Royalty Revenue
Performance
R&D Overview
Acorda Therapeutics Inc - Corporate Strategy
Acorda Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Acorda Therapeutics Inc - Strengths
Acorda Therapeutics Inc - Weaknesses
Acorda Therapeutics Inc - Opportunities
Acorda Therapeutics Inc - Threats
Acorda Therapeutics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Acorda Therapeutics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 04, 2021: Acorda Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 19, 2021: Acorda Therapeutics announces departure of Chief, Business Operations
Nov 03, 2020: Acorda reports third quarter 2020 financial results
Aug 04, 2020: Acorda reports second quarter 2020 financial results
Jul 14, 2020: Acorda Therapeutics receives U.S. income tax refund
May 05, 2020: Acorda reports first quarter 2020 financial results and provides business update
Apr 27, 2020: Acorda Therapeutics took $5-10 million PPP government loan for COVID-19-struck small businesses, FOIA request shows
Feb 13, 2020: Acorda Therapeutics provides business update and reports fourth quarter and full year 2019 financial results
Jan 15, 2020: Acorda provides 2019 highlights and 2020 guidance at J.P. Morgan Healthcare Conference

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Acorda Therapeutics Inc, Key Facts
Acorda Therapeutics Inc, Key Employees
Acorda Therapeutics Inc, Key Employee Biographies
Acorda Therapeutics Inc, Major Products and Services
Acorda Therapeutics Inc, History
Acorda Therapeutics Inc, Other Locations
Acorda Therapeutics Inc, Subsidiaries
Acorda Therapeutics Inc, Key Competitors
Acorda Therapeutics Inc, Ratios based on current share price
Acorda Therapeutics Inc, Annual Ratios
Acorda Therapeutics Inc, Annual Ratios (Cont...1)
Acorda Therapeutics Inc, Annual Ratios (Cont...2)
Acorda Therapeutics Inc, Interim Ratios
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Acorda Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Acorda Therapeutics Inc, Performance Chart (2016 - 2020)
Acorda Therapeutics Inc, Ratio Charts
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021